These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36629206)

  • 1. Therapeutic efficacy of oscillating positive expiratory pressure therapy in stable chronic obstructive pulmonary disease.
    Gupta A; Sodhi MK; Jaggi S; Aggarwal D; Saini V
    Lung India; 2022; 39(5):449-454. PubMed ID: 36629206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oscillatory Positive Expiratory Pressure in Chronic Obstructive Pulmonary Disease.
    Svenningsen S; Paulin GA; Sheikh K; Guo F; Hasany A; Kirby M; Rezai RE; McCormack DG; Parraga G
    COPD; 2016; 13(1):66-74. PubMed ID: 26430763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Aerobika
    Sahardin SN; Jailaini MFM; Abeed NNN; Ban AY; Hau NB; Azmel AA; Shah SA; Hamid MFA
    Front Med (Lausanne); 2023; 10():1202380. PubMed ID: 37332765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An initial evaluation of the safety of a disposable oscillating positive expiratory pressure device in patients with chronic obstructive pulmonary disease: a sort-term pilot study.
    O'Sullivan KJ; Power V; Linnane B; McGrath D; Fogarty H; Ryan M; White R; Noonan C; Mulloy E; O'Sullivan LW; Dunne CP
    BMC Pulm Med; 2021 Oct; 21(1):326. PubMed ID: 34666748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Airway clearance techniques for bronchiectasis.
    Lee AL; Burge AT; Holland AE
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008351. PubMed ID: 26591003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Oscillating Positive Expiratory Pressure Device Use on Post-Discharge Hospitalizations: A Retrospective Cohort Study Comparing Patients with COPD or Chronic Bronchitis Using the Aerobika
    Tse J; Wada K; Wang Y; Coppolo D; Kushnarev V; Suggett J
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2527-2538. PubMed ID: 33116469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COPD exacerbations and patient-reported outcomes according to post-bronchodilator FEV
    Chai CS; Ng DL; Bt Mos S; Ibrahim MAB; Tan SB; Pang YK; Liam CK
    BMC Pulm Med; 2023 Apr; 23(1):150. PubMed ID: 37118725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway clearance devices for cystic fibrosis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(26):1-50. PubMed ID: 23074531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of severity of chronic obstructive pulmonary disease with health-related quality of life and six-minute walk test in a rural hospital of central India.
    Agrawal SR; Joshi R; Jain A
    Lung India; 2015; 32(3):233-40. PubMed ID: 25983408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of transcutaneous electrical acupoint stimulation on lung function and risks of exacerbation for patients with chronic obstructive pulmonary disease].
    Xiao X; Li S; Wang Y; Lei DM; Zhang X; Zhao FR; Huang W
    Zhen Ci Yan Jiu; 2021 Jul; 46(7):598-604. PubMed ID: 34369681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Airway clearance techniques for bronchiectasis.
    Lee AL; Burge A; Holland AE
    Cochrane Database Syst Rev; 2013 May; (5):CD008351. PubMed ID: 23728674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of different evaluation systems for assessing disease severity and treatment efficacy in patients with chronic obstructive pulmonary disease].
    Tan M; Jian W; Liang Q; Li S; Cui H
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jul; 41(7):1119-1124. PubMed ID: 34308866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).
    Ni H; Moe S; Soe Z; Myint KT; Viswanathan KN
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011594. PubMed ID: 30536566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?
    Morishita-Katsu M; Nishimura K; Taniguchi H; Kimura T; Kondoh Y; Kataoka K; Ogawa T; Watanabe F; Arizono S; Nishiyama O; Nakayasu K; Imaizumi K; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1543-51. PubMed ID: 27462150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of additional long-term use of bottle-positive expiratory pressure in chronic obstructive pulmonary disease: A single-blind, randomized study.
    Keniş-Coşkun Ö; Kocakaya D; Kurt S; Fındık B; Yağcı İ; Eryüksel E
    Turk J Phys Med Rehabil; 2022 Jun; 68(2):195-204. PubMed ID: 35989964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digital interventions for the management of chronic obstructive pulmonary disease.
    Janjua S; Banchoff E; Threapleton CJ; Prigmore S; Fletcher J; Disler RT
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013246. PubMed ID: 33871065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary rehabilitation: A novel adjunct in management of obstructive sleep apnea.
    Agarwal P; Garg K; Saini V; Singh I
    Monaldi Arch Chest Dis; 2022 Jun; 93(1):. PubMed ID: 35723643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Functional Respiratory Imaging Approach to the Effect of an Oscillating Positive Expiratory Pressure Device in Chronic Obstructive Pulmonary Disease.
    Leemans G; Belmans D; Van Holsbeke C; Kushnarev V; Sugget J; Ides K; Vissers D; De Backer W
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1261-1268. PubMed ID: 32581531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
    Calverley PM; Postma DS; Anzueto AR; Make BJ; Eriksson G; Peterson S; Jenkins CR
    Int J Chron Obstruct Pulmon Dis; 2016; 11():381-90. PubMed ID: 26952309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.